Newsroom | 75046 results

DÜSSELDORF, Deutschland--(BUSINESS WIRE)--Verbraucher bevorzugen Produkte mit nachgewiesener Wirksamkeit gegenüber solchen mit neuartigen Inhaltsstoffen, was laut einer neuen Studie des Marktforschungsunternehmens Euromonitor International Wachstumschancen in den Bereichen Lebensmittel, Getränke und Schönheitspflege eröffnet. Der weltweite Umsatz mit Lebensmitteln und Getränken im Gesundheits- und Wellnessbereich wird 2026 voraussichtlich mehr als 1 Billion US-Dollar erreichen, während Verbrauc...

ATLANTA--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in Georgia announced a new partnership with Brokers Holding Group, a Warner Pacific leading general agency serving health insurance brokers, to expand marketing and distribution opportunities for Anthem's health benefits solutions in Georgia's small and mid-market employer segments. Through the relationship, Anthem and Brokers Holding Group will work together to strengthen engagement with insurance brokers across Georgia, helping them...

HAYWARD, Calif.--(BUSINESS WIRE)--Aarvik Therapeutics (Aarvik), an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer therapy, is pleased to announce important updates to its partnership efforts. Dosing of the first patient in a Phase 1 trial in the US for AV-P138-ADC (ARR-002) was recently announced by Aarvik’s research collaboration partner, ArriVent Biopharma, Inc. (ArriVent; Nasdaq: AVBP). AV-P138-ADC (ARR-002) is the first MUTTA™-based ADC...

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will attend the Stephens Investment Conference in Nashville, TN, on Wednesday, November 18, 2026. Fred Burke, President and Chief Executive Officer, will participate in a fireside chat at 9:30 a.m. Central Standard Time. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation accessible through Guardian Pharmacy Service’s webs...

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today announced results for the third quarter ended September 30, 2026. Third Quarter 2026 Revenues of $83.3 million, up 8.9% from $76.5 million in the third quarter of 2025 Operating income of $6.6 million, down 13.0% from $7.6 million in the third quarter of 2025 Net income of $5.4 million, down 11.7% from $6.1 million in the...

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two investor conferences in November. On Monday, November 9, 2026, the Company will participate in the 2026 UBS Global Healthcare Conference. The Company’s presentation will begin at 11:00 a.m. Eastern Time/10:00 a.m. Central Time. On Wednesday, November 18, 2026, the Company will participate in the 2026 Stephens Annual Investment Conference. The Company’s presen...

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Van’s Institutional Pharmacy, a long-term care pharmacy based in Martin, Tennessee....

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Monday, November 9 at 9:00 a.m. Eastern Time to discuss its third quarter 2026 financial results and highlight progress on key programs. The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address. About Ionis Pharmaceuticals, Inc. For three decades, Ionis has invented...

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update. “Our strong performance continues to reflect our ability to deliver exceptional clinical outcomes, a better healthcare experience and lower client costs at scale," said Daniel Perez, Co-Founder and CEO, Hinge Health. "This focus on the triple aim, via a technology platform that scales and automates care delivery, is also...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference on November 10, 2026 at 11:30 a.m. ET in Boston, MA.Interested parties can...